by Leslie Small
Although Cigna Corp. ended 2021 with earnings that exceeded Wall
Street expectations, the company also reported continued struggles with
elevated medical costs last year. Further, the insurer disclosed that it
expects less Medicare Advantage growth than it originally anticipated in 2022
and a decline in individual/family plan enrollment.
COVID raised medical costs in 2021
- For the fourth quarter of 2021, Cigna reported adjusted earnings per share (EPS) of $4.77,
beating the consensus estimate of $4.50. Cigna’s full-year adjusted EPS
was $20.47, reflecting year-over-year growth of 11% that the company said
was largely driven by the Evernorth health services segment.
- The insurer’s medical loss ratio (MLR) of 87% for the
fourth quarter was higher — or worse — than the consensus estimate of
85.5%. And Cigna’s full-year 2021 MLR was 84%.
- During a Feb. 3 conference call to discuss quarterly
and full-year earnings, CEO David Cordani acknowledged that the company
struggled throughout the year with elevated medical costs in its
commercial and stop-loss businesses, in part due to the impact of COVID
testing, treatment and vaccine costs.
- “The unfavorable fourth-quarter medical costs informed
and sharpened our 2022 assumptions,” Chief Financial Officer Brian Evanko
added during his prepared remarks. Therefore, Cigna’s “2022 medical costs
outlook is now higher than our previous expectations,” he said, later
estimating that the company’s MLR will be in the range of 82% to
83.5%.
Cigna expects ‘flat’ MA membership in 2022
- Cigna also forecasts its MA membership in 2022 “to be
relatively flat compared to 2021” and anticipates that its
individual/family plan membership will decline this year.
- The company had expected 2022 to be “a bit more [of] a
dynamic year from an MA standpoint,” Cordani said during the
question-and-answer portion of the call. “Hence we managed our portfolio
to reduce our internal expectations of life growth and focus on market
expansion with an eye toward…2023’s growth being a more accelerated growth
environment.”
- For Cigna’s individual market business, the insurer
ended 2021 with about 378,000 lives, according to Evanko. With the
Affordable Care Act open enrollment period now over in most states, Cigna
expects its individual market membership to be 20-25% lower than its
year-end enrollment figure, he said.
- Later, Cordani defended the strategy, stating that
“adding more lives at zero or negative margin is not a shareholder-prudent
posture.”
Subscribers may read the in-depth article online. Learn more about subscribing to AIS Health's publications.
No comments:
Post a Comment